| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_61f88efcda59d7062a4252ecf6886f58 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-5434
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-54 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-54 |
| filingDate |
2014-04-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f728c6a87e4ff74a335af142f73fd1ca
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_97e9c8eb297b023852b5191e3a11bc7c |
| publicationDate |
2014-07-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2014206758-A1 |
| titleOfInvention |
Expression of il-12 family heterodimers |
| abstract |
The present invention provides methods of improving the levels and stability of expression of interleukin-12 family cytokine polypeptides by expressing the alpha and beta subunits of the polypeptides at their determined relative molar ratios that increase the levels and stability of expression of the heterodimer, e.g., in comparison to heterodimer expressed at an equimolar ratio. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105085656-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11311602-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11421011-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11000573-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10646549-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11571463-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9546202-B2 |
| priorityDate |
2008-05-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |